A Multicenter, Observational, Longitudinal Study To Evaluate The Efficacy and Safety of Combination of Sofosbuvir and Daclatasvir In Patients With Chronic Hepatitis C.
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2015
At a glance
- Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Acronyms APROVVIE 2
- 10 Aug 2015 New trial record
- 26 Apr 2015 Interim results presented at the 50th Annual Meeting of the European Association for the Study of the Liver (n = 140).